Asset Allocation

As of December 31, 2025.
Type % Net
Cash 8.24%
Stock 80.34%
Bond 8.08%
Convertible 0.00%
Preferred 0.00%
Other 3.34%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 81.83%
Mid 14.73%
Small 3.44%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 89.28%    % Emerging Markets: 0.00%    % Unidentified Markets: 10.72%

Americas 87.06%
86.93%
Canada 0.04%
United States 86.89%
0.14%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 2.10%
United Kingdom 0.42%
1.54%
France 0.02%
Germany 0.00%
Ireland 1.18%
Netherlands 0.08%
Switzerland 0.25%
0.00%
0.15%
Israel 0.15%
Greater Asia 0.11%
Japan 0.01%
0.01%
Australia 0.01%
0.09%
Singapore 0.08%
South Korea 0.01%
0.00%
Unidentified Region 10.72%

Bond Credit Quality Exposure

AAA 9.12%
AA 2.29%
A 2.68%
BBB 4.95%
BB 1.02%
B 0.32%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.80%
Not Available 77.83%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
25.35%
Materials
1.69%
Consumer Discretionary
9.75%
Financials
12.27%
Real Estate
1.64%
Sensitive
51.61%
Communication Services
9.75%
Energy
2.59%
Industrials
7.27%
Information Technology
31.99%
Defensive
15.11%
Consumer Staples
4.19%
Health Care
8.84%
Utilities
2.07%
Not Classified
7.92%
Non Classified Equity
0.13%
Not Classified - Non Equity
7.80%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 71.45%
Corporate 6.70%
Securitized 21.22%
Municipal 0.00%
Other 0.64%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
72.53%
Less than 1 Year
72.53%
Intermediate
8.39%
1 to 3 Years
3.86%
3 to 5 Years
2.54%
5 to 10 Years
1.99%
Long Term
18.85%
10 to 20 Years
7.18%
20 to 30 Years
7.00%
Over 30 Years
4.68%
Other
0.22%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial